The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. The National Academies Collection: Reports funded by National Institutes of Health. Washington, DC: National Institutes of Health, 2017.Google Scholar
Kelley-Baker T, Berning A, Ramirez A, Lacey JH, Carr K, Waehrer G, et al. 2013–2014 National Roadside Study of alcohol and drug use by drivers: drug results (Report No. DOT HS 812 411). Washington, DC: National Highway Traffic Safety Administration, 2017.Google Scholar
Broyd SJ, van Hell HH, Beale C, Yucel M, Solowij N. Acute and chronic effects of cannabinoids on human cognition – a systematic review. Biol Psychiatry 2016;79:557–67.CrossrefWeb of SciencePubMedGoogle Scholar
Compton R. Marijuana-impaired driving – a report to congress (DOT HS 812 440). Washington, DC: National Highway Traffic Safety Administration, 2017.Google Scholar
Biecheler M-B, Peytavin J-F, the SAMG, Facy F, Martineau H. SAM survey on “drugs and fatal accidents”: search of substances consumed and comparison between dInvolved under the influence of alcohol or cannabis. Traffic Injury Prev 2008;9:11–21.CrossrefGoogle Scholar
Logan B, Kacinko SL, Beirness DJ. An evaluation of data from drivers arrested for driving under the influence in relation to per se limits for cannabis. AAA Foundation for Traffic Safety, 2016. https://aaafoundation.org/wp-content/uploads/2017/12/ EvaluationOfDriversInRelationToPerSeReport.pdf.
Hartman RL, Brown TL, Milavetz G, Spurgin A, Gorelick DA, Gaffney GR, et al. Effect of blood collection time on measured delta9-tetrahydrocannabinol concentrations: implications for driving interpretation and drug policy. Clin Chem 2016;62:367–77.PubMedCrossrefGoogle Scholar
Schwope DM, Bosker WM, Ramaekers JG, Gorelick DA, Huestis MA. Psychomotor performance, subjective and physiological effects and whole blood Delta(9)-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis. J Anal Toxicol 2012;36:405–12.CrossrefPubMedGoogle Scholar
Bergamaschi MM, Karschner EL, Goodwin RS, Scheidweiler KB, Hirvonen J, Queiroz RH, et al. Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers’ blood on per se drugged driving laws. Clin Chem 2013;59:519–26.PubMedWeb of ScienceCrossrefGoogle Scholar
Newmeyer MN, Swortwood MJ, Barnes AJ, Abulseoud OA, Scheidweiler KB, Huestis MA. Free and glucuronide whole blood cannabinoids’ pharmacokinetics after controlled smoked, vaporized, and oral cannabis administration in frequent and occasional cannabis users: identification of recent cannabis intake. Clin Chem 2016;62:1579–92.Web of ScienceCrossrefPubMedGoogle Scholar
Scheidweiler KB, Schwope DM, Karschner EL, Desrosiers NA, Gorelick DA, Huestis MA. In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis. Clin Chem 2013;59:1108–17.CrossrefPubMedWeb of ScienceGoogle Scholar
Himes SK, Scheidweiler KB, Beck O, Gorelick DA, Desrosiers NA, Huestis MA. Cannabinoids in exhaled breath following controlled administration of smoked cannabis. Clin Chem 2013;59:1780–9.Web of SciencePubMedCrossrefGoogle Scholar
Sobolesky PM, Smith BE, Hubbard JA, Stone J, Marcotte TD, Grelotti DJ, et al. Validation of a liquid chromatography-tandem mass spectrometry method for analyzing cannabinoids in oral fluid. Clin Chim Acta 2019;491:30–8.CrossrefWeb of SciencePubMedGoogle Scholar
Rudzki PJ, Gniazdowska E, Bus-Kwasnik K. Quantitative evaluation of the matrix effect in bioanalytical methods based on LC-MS: a comparison of two approaches. J Pharm Biomed Anal 2018;155:314–9.PubMedCrossrefWeb of ScienceGoogle Scholar
Hadener M, Weinmann W, Schurch S, Konig S. Development of a rapid column-switching LC-MS/MS method for the quantification of THCCOOH and THCCOOH-glucuronide in whole blood for assessing cannabis consumption frequency. Anal Bioanal Chem 2016;408:1953–62.Web of SciencePubMedCrossrefGoogle Scholar
Konig S, Aebi B, Lanz S, Gasser M, Weinmann W. On-line SPE LC-MS/MS for the quantification of Delta9-tetrahydrocannabinol (THC) and its two major metabolites in human peripheral blood by liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 2011;400:9–16.PubMedCrossrefGoogle Scholar
Palazzoli F, Citti C, Licata M, Vilella A, Manca L, Zoli M, et al. Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC-MS/MS) method for the determination of cannabidiol (CBD), Delta(9)-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD. J Pharm Biomed Anal 2018;150:25–32.PubMedWeb of ScienceGoogle Scholar
Schwope DM, Scheidweiler KB, Huestis MA. Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2011;401:1273–83.Web of SciencePubMedCrossrefGoogle Scholar
Teixeira H, Verstraete A, Proenca P, Corte-Real F, Monsanto P, Vieira DN. Validated method for the simultaneous determination of Delta9-THC and Delta9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography-mass spectrometry with electrospray ionization. Forensic Sci Int 2007;170:14–55.Google Scholar
Tiscione NB, Miller R, Shan X, Sprague J, Yeatman DT. An efficient, robust method for the determination of cannabinoids in whole blood by LC-MS-MS. J Anal Toxicol 2016;40:639–48.PubMedCrossrefWeb of ScienceGoogle Scholar
Fell JC, Scherer M. Estimation of the potential effectiveness of lowering the blood alcohol concentration (BAC) limit for driving from 0.08 to 0.05 grams per deciliter in the United States. Alcohol Clin Exp Res 2017;41:2128–39.PubMedCrossrefWeb of ScienceGoogle Scholar
Lynch KL, Luo YR, Hooshfar S, Yun C. Correlation of breath and blood Delta(9)-tetrahydrocannabinol concentrations and release kinetics following controlled administration of smoked cannabis. Clin Chem 2019. pii: clinchem.2019.304501. doi: 10.1373/clinchem.2019.304501 [Epub ahead of print].Google Scholar
Coucke L, Massarini E, Ostijn Z, Beck O, Verstraete AG. Delta(9)-Tetrahydrocannabinol concentrations in exhaled breath and physiological effects following cannabis intake – a pilot study using illicit cannabis. Clin Biochem 2016;49:1072–7.Web of ScienceCrossrefPubMedGoogle Scholar
Luo YR, Yun C, Lynch KL. Quantitation of cannabinoids in breath samples using a novel derivatization LC-MS/MS assay with ultra-high sensitivity. J Anal Toxicol 2019;43:331–9.CrossrefWeb of SciencePubMedGoogle Scholar
Garzinsky AM, Walpurgis K, Krug O, Thevis M. Does oral fluid contribute to exhaled breath samples collected by means of an electret membrane? Drug Test Anal 2019. doi: 10.1002/dta.2597. [Epub ahead of print].PubMedGoogle Scholar
Sorensen LK, Hasselstrom JB. Sensitive determination of cannabinoids in whole blood by LC-MS-MS after rapid removal of phospholipids by filtration. J Anal Toxicol 2017;41:382–91.PubMedWeb of ScienceCrossrefGoogle Scholar
Scheidweiler KB, Newmeyer MN, Barnes AJ, Huestis MA. Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry. J Chromatogr A 2016;1453:34–42.CrossrefPubMedWeb of ScienceGoogle Scholar
Hanisch S, Paulke A, Toennes SW. 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol glucuronide exhibits acyl-migration isomers. J Pharm Biomed Anal 2017;146:261–5.Web of ScienceCrossrefPubMedGoogle Scholar
About the article
Published Online: 2019-09-17
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This work was supported by the State of California via the Medical Marijuana Regulation and Safety Act (Assembly Bill 266). Additional support was provided by the Center for Medicinal Cannabis Research at the University of California, San Diego, which receives support from the Control, Regulate, and Tax Adult Use of Marijuana Act (California Proposition 64) and philanthropic gifts from the Wholistic Research and Education Foundation.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.